What Do Pharmaceuticals Really Cost in the Long Run?
This study found that brand price at launch and generic entry overstates long-run average pharmaceutical costs, with and without accounting for medical cost offsets.
Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and Prospects
Assessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.
